Home > Izotropic Corp. IZOZF > Page 2

Tag: Izotropic Corp. IZOZF

TuesdayAug 19, 2025 10:50 am

QualityStocksNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Launches BreastCT.com to Advance Awareness of Dedicated Breast CT Technology

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company commercializing imaging-based products for more accurate breast cancer screening, diagnoses, and treatment, announced the launch of BreastCT.com, a new online platform supporting its awareness initiatives. The site serves as a central educational resource on dedicated breast CT technology and Izotropic’s IzoView Breast CT Imaging System, emphasizing its potential to address challenges in detecting cancer in the 50% of women with dense breast tissue. With IzoView’s engineering complete, the platform will evolve with the Company through clinical study preparation, U.S. and global regulatory phases, and ongoing awareness programs leading to…

Continue Reading

TuesdayAug 19, 2025 9:45 am

Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF): How a $500K Device Could Reshape the $8.7 Billion Breast Imaging Market

IzoView Breast CT targets aggressive market displacement with up to 67% lower pricing than competing breast CT systems, positioning at $500K versus competitors priced up to $1.5 million True 360-degree 3D imaging without compression positioned to bridge the clinical gap between standard screening and MRI, offering 100x greater spatial resolution than MRI at significantly lower cost Platform approach enables 14 potential future indications across screening, diagnosis, monitoring, and treatment planning through software upgrades, creating scalable revenue expansion without hardware replacement Every year, outdated imaging technologies underperform for the roughly half of women undergoing breast cancer screening who have dense breast…

Continue Reading

FridayAug 08, 2025 9:00 am

Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF): The Cancer Detection Revolution That Could Make Breast Cancer Deaths Preventable

Izotropic's IzoView Breast CT Imaging System represents a breakthrough in dedicated breast imaging technology, addressing persistent limitations in conventional screening methods through proprietary hardware and software FDA regulatory pathway alignment clears the path for a pivotal U.S. clinical study, with the company completing a comprehensive 150-page strategic business plan and advanced financial modeling for commercialization Strategic awareness initiatives including dedicated breastct.com platform and podcast series position the company for market education as breast CT technology emerges as the next generation of cancer detection The medical community stands at the threshold of what could become the most significant advancement in cancer…

Continue Reading

ThursdayAug 07, 2025 10:30 am

Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) Advancing Next-Gen Breast Cancer Imaging

Breast cancer continues to be the most commonly diagnosed cancer among U.S. women, excluding nonmelanoma skin cancer Izotropic is preparing to revolutionize breast cancer imaging with its flagship IzoView Breast CT Imaging System In anticipation of future commercialization, Izotropic is initiating a strategic awareness and engagement campaign Accurate detection and diagnosis remain critical challenges in the fight against breast cancer, especially for women with dense breast tissue where mammography falls short. Izotropic (CSE: IZO) (OTCQB: IZOZF) is at the forefront of addressing these gaps through its IzoView Breast CT Imaging System, a contrast-enhanced CT platform designed for enhanced screening precision.…

Continue Reading

ThursdayAug 07, 2025 9:50 am

QualityStocksNewsBreaks – Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) Launches Multilingual Podcast to Raise Awareness of Breast Imaging Innovation

Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company advancing imaging technologies for breast cancer detection, has launched a multilingual podcast series titled Beyond the Mammogram: Rethinking the Future of Breast Imaging. Available in seven languages, the series aims to inform global audiences about limitations in current imaging tools and the need for more accurate technologies like Izotropic’s IzoView Breast CT system. The podcast repurposes public data into educational content for patients, professionals, and stakeholders as the Company moves toward regulatory approval. To view the full press release, visit https://ibn.fm/FDgr9 About Izotropic More information about Izotropic Corporation can…

Continue Reading

TuesdayJul 29, 2025 1:45 pm

Why Izotropic Corp. (CSE: IZO) (OTCQB: IZOZF) Is ‘One to Watch’

Izotropic is the only commercial entity with exclusive global rights to the Breast CT technology developed at UC Davis. The company has secured regulatory alignment with the FDA and is preparing for a pivotal U.S. clinical trial. IzoView offers a proprietary, patient-centric alternative to mammography for dense breast tissue imaging. A comprehensive business and financial plan supports execution across clinical, regulatory, and commercial milestones. Awareness campaigns, including breastct.com and a company podcast, are primed to drive engagement and investor visibility. Izotropic (CSE: IZO) (OTCQB: IZOZF) is a medical device company advancing dedicated imaging solutions to improve the screening, diagnosis, and treatment of…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered

512.354.7000

Please read Disclaimers for FULL Compensation Disclosures and other disclaimers.

Copyright © .